Io Biotech Inc (IOBT) Return on Assets ROA from the third quarter of 2025 to third quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Io Biotech Inc   (NASDAQ: IOBT)


Io Biotech Inc 's ROA from the third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Io Biotech Inc 's ROA in the third quarter of 2025?
Io Biotech Inc recorded a cumulative net loss of $-88 million during 12 months ending in the third quarter of 2025, resulting in a negative return on assets (ROA) of -178.86%.

However, within the Healthcare sector 867 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2025 quarter, so far to 4580, from total ROA ranking in the second quarter of 2025 at 4630.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Total Assets Change -55.73 % -61.57 % -64.58 % -52.75 % -48 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -88 -104 -98 -95 -90
Return On Assets (TTM) -178.86 % -168.3 % -124.73 % -96.04 % -75.86 %
IOBT's Total Ranking # 4580 # 4630 # 4615 # 5194 # 4476
Total Assets (TTM) in million 39 43 45 70 89
Seq. Total Assets Change -8 % -4.8 % -36.18 % -20.79 % -20.15 %
Seq. Net Income Change - - - - -

IOBT's 5 Years Annual ROA >> Back to IOBT Management Effectiveness >> Compare IOBT ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 415
Sector # 868
Overall # 4523

Return On Assets Statistics
High Average Low
-21.66 %
-77.39 %
-180.56 %
(Jun 30 2022)   (Sep 30 2025)



  News about Io Biotech Inc Return on Assets ROA

IO Biotech Takes Bold Steps to Overcome Financial Woes and Drive Commercialization Readiness

IO Biotech Expands Senior Leadership Team to Drive Commercialization Readiness Despite Cumulative Net Losses
IO Biotech Inc, a leading biotechnology company in the healthcare sector, has recently announced the expansion of its senior leadership team as part of its strategy to progress towards commercialization readiness. This move comes in the face of significant financial challenges, with the company recording a staggering cumulative net loss of $-80 million during the 12 months ending in the third quarter of 2023. This resulted in a negative return on assets (ROA) of -55.93%.
The decision to augment its senior leadership team reflects IO Biotech s determination to overcome its financial predicament and drive the company forward. By bringing in experienced professionals who can provide valuable expertise and guidance, IO Biotech aims to bolster its commercialization efforts and pave the way for future success.



Financial Statements
Io Biotech Inc 's Assets $ 39 million IOBT's Balance sheet
Io Biotech Inc 's Income $ -8 million Quarterly IOBT's Income Statement
IOBT's Income by Division See IOBT's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
FY
Y / Y Total Assets Change -54.67 % -0.57 % -32.54 % - -
Total Assets in million 68 149 150 222 0
Y / Y Net Income Change - - - - -
Net Income in million -95 -86 -71 -68 0
Annual Return On Assets -141.28 % -57.73 % -47.65 % -30.54 % -

IOBT's 5 Years Annual ROA >> Back to IOBT Management Effectiveness >> Compare IOBT ROA to its Competitors



More Return On Assets Ratios
IOBT's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IOBT's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IOBT's Competitors
Subscribers only: Roa for Io Biotech Inc 's Suppliers
Subscribers only: Return On Assets for IOBT's Customers

You may also want to know
IOBT's Roi IOBT's Inventory Turnover Ratio IOBT's Growth Rates IOBT's Dividend Comparisons
IOBT's Profitability Ratios IOBT's Asset Turnover Ratio IOBT's Dividend Growth
IOBT's Roe IOBT's Valuation Ratios IOBT's Financial Strength Ratios IOBT's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2025, within Healthcare Sector ROA

Date modified: 2026-08-30T15:03:35+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.